Anatomic Pathology Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Anatomic Pathology Market covers analysis by Product and Service (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others), End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00002999
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 200
Buy Now

The anatomic pathology market is expected to grow from US$ 22,800.20 million in 2022 to US$ 33,145.78 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2031.

Anatomic pathology is a significant part of the study and treatment of diseases. It is a broad field that includes decedent pathology, surgical pathology, cytopathology, neuropathology, and ophthalmic pathology. It is usually performed in medical laboratories of hospitals and diagnostic laboratories. The market growth is attributed to the increasing prevalence of cancer and other diseases and growing focus on personalized medicines. However, the lack of skilled professionals and stringent government regulations are hampering the market growth. 

The anatomic pathology market is segmented on the basis of product and service, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing various parameters such as market trends, technological advancements, market dynamics and the competitive landscape of leading global market players.

Strategic Insights

Lucrative Regions for Anatomic Pathology Market

Lucrative Regions for Anatomic Pathology Market

Market Insights

Development of New Technologies and Launch of Products

There is a huge scope for the integration of machine learning (ML) and artificial intelligence (AI)-based systems in medical streams, including anatomic pathology. Several anatomic pathology laboratories are becoming increasingly aware of the benefits of digitization and AI in practice. Moreover, recent technological advancements and regulatory approvals are encouraging the digitalization of laboratories’ operations to improve the speed and accuracy of processes. Properly designed AI-based tools hold immense potential to improve workflow efficiency and diagnostic accuracy in pathology. AI technology can enhance the pathology imaging, which is enabling greater precision in diagnosis and leading to disease-specific treatment. 

Digital pathology, a growing subfield within anatomical pathology, uses digital technologies to streamline data collection and management. It helps reduce risks to specimen samples and has the potential to accelerate enrolment in clinical trials. Moreover, it can reduce sample-to-result turnaround time and streamline the central pathology review process, thus offering opportunities to increase trial efficiency.

In 2018, Sakura Finetek USA, Inc. commercialized Accu-Cut SRM 300 LT, a manual microtome. This manual microtome with innovative features is designed to simplify the visualization of paraffin-embedded tissue samples and enable safer sectioning. The Accu-Cut SRM 300 LT has many exclusive user safety features that reduce the risk of accidental injuries associated with blade exposure. Various market players are focused on introducing innovative solutions. For instance, RadNet, an imaging service provider, and Hologic, a diagnostic product developer, collaborated to develop AI tools for breast health. Thus, the introduction of new technologies and products is likely to emerge as a significant trend in the anatomic pathology market during the forecast period.

Product and Service Insights

Based on product and service, the global anatomic pathology market is segmented into instruments, consumables, and services. The services segment held the largest market share in 2022; however, the instruments segment is anticipated to register the highest CAGR of 7.0% during the forecast period.

Application Insights

Based on application, the anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment is likely to hold the largest share of the market in 2022; however, the drug discovery and development segment is anticipated to register the highest CAGR of 7.0% during the forecast period.

End User Insights

Based on end user, the anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The others segment includes pharmaceutical and biotechnology companies and contract research organizations (CROs). The hospitals segment held the largest share of the market in 2022; however, the diagnostic laboratories segment is anticipated to register the highest CAGR of 7.0% during the forecast period.

Anatomic Pathology Market, by End User – 2022 to 2031

Anatomic Pathology Market, by End User – 2022 to 2031

Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global anatomic pathology market. A few of the recent key developments are listed below:

  • In September 2021, Roche launched the Digital Pathology Open Environment to encourage software developers to collaborate to enhance patient outcomes and increase personalized healthcare through novel image analysis technologies.
  • In May 2021, BioGenex launched CD8A, CD56, and CD163, the three primary immunohistochemistry (IHC) antibodies for cancer diagnosis.
  • In August 2021, in the US, BD introduced a completely automated high-throughput diagnostic system that uses robotics and sample management software algorithms. The system created a benchmark in automation for infectious disease molecular testing in core laboratories and other centralized labs.
  • In July 2021, BD announced the commercial launch of bdbiosciences.com web and e-commerce site, a completely "reimagined" digital marketplace to offer consumers and their procurement teams a better online purchase experience.

The COVID-19 pandemic and the disruption it caused in healthcare resources impacted every aspect of the diagnostics industry, including the anatomic pathology market. The shutdown of clinics, operation rooms, and physicians’ offices and the “stay-at-home” mandates across the globe severely affected the acquisition and submission of specimens for pathological evaluation. In 2020 and 2021, the number of patient visits to hospitals reduced significantly, despite emergency and OPD services being available in hospitals. Further, most hospitals invested their efforts and resources in diagnosing and treating COVID-19; as a result, many planned surgeries were canceled or delayed. Hence, various early cancer detection systems were deactivated, and most of autopsies were suspended. This situation hampered the medical care of patients with illnesses other than COVID-19, including patients with chronic diseases, oncology patients, or those awaiting organ transplantation. Consequently, the number of surgical pathology and cytology samples received in anatomic pathology labs was reduced.

Anatomic Pathology – Market Segmentation

Based on product and service, the global anatomic pathology market is segmented into instruments, consumables, and services. Based on application, the anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. Based on end user, the anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. Based on geography, the market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Company Profiles

  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Hologic, Inc.
  • Agilent Technologies, Inc.
  • BioGenex
  • Diapath S.p.A.
  • Bio SB
  • Merck KGaA
  • BD
  • PHC Holdings Corporation

RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
REGIONAL FRAMEWORK
World Geography
Strategic Insights

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS
biotechnology
Research Criteria
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product and Service, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are anatomic pathology?

Anatomic pathology is a field of medicine devoted to studying diseases and disease progression based on the macroscopic, microscopic, biochemical, immunologic, and molecular examination of organs and tissues. It includes tissue specimen evaluations, including cervical scrapings (i.e., PAP smears), biopsies, surgical resections, and whole-body evaluations after autopsy.

What are the driving factors for the anatomic pathology market across the globe?

Key factors that are driving the growth of this market are increase in prevalence of cancer and other disease, and growing focus on personalized medicines.

Which product and service led the anatomic pathology market?

The services segment dominated the global anatomic pathology market and held the largest revenue share of 40.04% in 2021.

Which application held the largest share in the anatomic pathology market?

The disease diagnosis dominated the global anatomic pathology market and held the largest revenue share of 38.46% in 2021.

Which end-user held the largest share in the anatomic pathology market?

The hospitals segment dominated the global anatomic pathology market and accounted for the largest revenue share of 48.52% in 2021.

Who are the key players in the anatomic pathology market?

The anatomic pathology market majorly consists of the players such as F. Hoffmann-La Roche AG, Danaher, Hologic, Inc, Agilent Technologies Inc, BioGenex, Diapath S.p.A, Bio SB, Merck KGaA, BD, PHC Holdings Corporation, among others.

What is the regional market scenario of anatomic pathology?

Global anatomic pathology market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for anatomic pathology. The US is estimated to hold the largest share in the anatomic pathology market during the forecast period. The growth of the market can be because of rise in cases of chronic diseases such as cancer, and increase in healthcare expenditure in the country. In addition, presence of major market players coupled with large number of funding programs by the public agencies in the region stimulate the growth of anatomic pathology market in North America. On the other hand, enormous number of ongoing developments and innovations in healthcare, and rising spending capabilities in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.

The List of Companies - Anatomic Pathology Market

  1. F.HOFFMANN-LA- ROCHE Ltd.
  2. Danaher
  3. Hologic, Inc.
  4. Agilent Technologies, Inc.
  5. BioGenex
  6. Diapath S.p.A
  7. Bio SB
  8. MERCK KGaA
  9. BD
  10. PHC Holdings Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Anatomic Pathology Market